Synthaverse

Synthaverse R&D per Employee

The R&D Spending per Employee of Synthaverse (SVE.WA) as of Oct 18, 2026 is 26.79 PLN. In the previous year, R&D Spending per Employee was 66.96 PLN — a change of -60.00% (lower).

R&D per Employee

26.79PLN

YoY

-60.00%

Last updated:

R&D Spending per Employee of Synthaverse is 2021 26.79 PLN. R&D Spending per Employee of Synthaverse was 2020 66.96 PLN. It decreases by -60.00% lower compared to the previous year.

The Synthaverse R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2017
9,361.61 PLN
Jan 1, 2018
10,799.11 PLN
Jan 1, 2020
66.96 PLN
Jan 1, 2021
26.79 PLN
The Synthaverse R&D per Employee history
YEARR&D per EmployeeYoY
26.79PLN-60.00%
66.96PLN-99.38%
10,799.11PLN+15.36%
9,361.61PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Synthaverse Stock analysis

What does Synthaverse do? Biomed Lublin is a Polish company that has been active in the production of serums and vaccines since 1950. It has grown to become a leading producer of biological substances and medical devices in Eastern Europe. The company was originally a state institution for the development of animal vaccines but was privatized after the political changes in the late 1980s. Since 2002, it has been listed on the Warsaw Stock Exchange and has expanded its focus. Biomed Lublin operates in four main areas: veterinary medicine, human medicine, diagnostics, and laboratory equipment. It has a strong reputation in the veterinary medicine field, offering vaccines and diagnostics for livestock and pets. The company is also involved in human medicine, producing vaccines and diagnostics exclusively in Poland. In the diagnostics field, Biomed Lublin has developed and manufactured a variety of test kits used in medical diagnostics. It also offers laboratory equipment such as microscopes, pipettes, and centrifuges for medical and biological testing in hospitals and laboratories. Overall, Biomed Lublin aims to continue expanding its presence in the biotech industry in Eastern Europe and providing high-quality and effective diagnostic and therapeutic solutions to improve the health of both humans and animals. Synthaverse is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Synthaverse stock

R&D Spending per Employee of Synthaverse is 26.79 PLN in 2021.

R&D Spending per Employee of Synthaverse changed from 66.96 PLN to 26.79 PLN, representing a -60.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Synthaverse since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Synthaverse historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Synthaverse

All Key Metrics — Synthaverse